Equillium, Inc. - Common Stock, par value $0.0001 per share (EQ)
CUSIP: 29446K106
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 65,456,657
- Total 13F shares
- 8,887,474
- Share change
- -2,504
- Total reported value
- $6,151,871
- Put/Call ratio
- 0%
- Price per share
- $0.69
- Number of holders
- 24
- Value change
- -$260,570
- Number of buys
- 11
- Number of sells
- 12
Quarterly Holders Quick Answers
What is CUSIP 29446K106?
CUSIP 29446K106 identifies EQ - Equillium, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 29446K106:
Top shareholders of EQ - Equillium, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Decheng Capital LLC |
13F
|
Company |
6.8%
|
4,447,308
|
$10,273,281 | — | 31 Mar 2024 | |
| TAKEDA PHARMACEUTICAL CO LTD |
13F
|
Company |
2.8%
|
1,824,977
|
$4,215,697 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.3%
|
841,948
|
$1,944,900 | — | 31 Mar 2024 | |
| Cota Capital Management, LLC |
13F
|
Company |
0.86%
|
562,278
|
$1,298,862 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.32%
|
209,200
|
$483,000 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.31%
|
199,728
|
$461,456 | — | 31 Mar 2024 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.3%
|
198,775
|
$459,170 | — | 31 Mar 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.17%
|
108,691
|
$249,000 | — | 31 Mar 2024 | |
| Callan Capital, LLC |
13F
|
Company |
0.15%
|
99,688
|
$230,279 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.08%
|
52,620
|
$121,552 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.08%
|
50,043
|
$115,599 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.06%
|
41,756
|
$96,456 | — | 31 Mar 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.06%
|
40,332
|
$93,167 | — | 31 Mar 2024 | |
| Integrated Wealth Concepts LLC |
13F
|
Company |
0.06%
|
40,000
|
$92,400 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.05%
|
35,049
|
$80,963 | — | 31 Mar 2024 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.05%
|
31,200
|
$72,072 | — | 31 Mar 2024 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.04%
|
25,000
|
$58,000 | — | 31 Mar 2024 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
15,500
|
$35,805 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.02%
|
14,654
|
$33,851 | — | 31 Mar 2024 | |
| Joel Rothman |
3/4/5
|
Chief Development Officer |
—
mixed-class rows
|
233,150
mixed-class rows
|
$33,727 | — | 02 Jan 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.02%
|
11,897
|
$27,483 | — | 31 Mar 2024 | |
| Ground Swell Capital, LLC |
13F
|
Company |
0.02%
|
11,433
|
$26,410 | — | 31 Mar 2024 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.02%
|
10,119
|
$23,375 | — | 31 Mar 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
7,359
|
$16,999 | — | 31 Mar 2024 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.01%
|
5,155
|
$11,000 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.01%
|
3,811
|
$8,803 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
1,151
|
$2,659 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0%
|
306
|
$707 | — | 31 Mar 2024 | |
| Ph.D. Yu Xu |
3/4/5
|
Director |
—
class O/S missing
|
20,000
|
— | — | 22 May 2024 |
Institutional Holders of Equillium, Inc. - Common Stock, par value $0.0001 per share (EQ) as of Q2 2024
As of 30 Jun 2024,
Equillium, Inc. - Common Stock, par value $0.0001 per share (EQ) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,887,474 shares.
The largest 10 holders included
Decheng Capital LLC, TAKEDA PHARMACEUTICAL CO LTD, VANGUARD GROUP INC, Cota Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, ADAR1 Capital Management, LLC, ACADIAN ASSET MANAGEMENT LLC, Callan Capital, LLC, and STATE STREET CORP.
This page lists
24
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
27
Q2 2024 holders
24
Holder diff
-3
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.